http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018289666-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72046362a91a0f0277abe5495e47790f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366 |
| filingDate | 2017-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5aa94e466f3fa64cfa403103e88cbc03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e4d258ebb250a71e5a01126d27ceb91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f85058708df3ccb2ea662c74d41bfef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3af0ef3dd23f5436f1b9e5379835931e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c5644f404ce697d2f8060a994c316a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52d59ae320e2fc5082eaab2e9b9d69f2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fc375adaf72bde8c37bedb09ec25e06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf521158749af5e8a7614574421caf50 |
| publicationDate | 2018-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2018289666-A1 |
| titleOfInvention | Flavonolignans for treatment of autoimmune inflammatory diseases |
| abstract | A method for reducing abnormalities in lipid metabolism and for reducing inflammation in a subject suffering from an autoimmune inflammatory disease accompanied by abnormalities in lipid metabolism includes administering an effective amount of a flavonolignan to the subject. The subject may additionally suffer from a liver disease, obesity, hypertension, diabetes mellitus or a metabolic syndrome. Further provided is a method for reducing the risk of a cardiovascular disease in a subject suffering from an autoimmune inflammatory disease accompanied by abnormalities in lipid metabolism and a method for reducing hepatic abnormalities and reducing inflammation in a subject suffering from an autoimmune inflammatory disease accompanied by hepatic abnormalities. Still further provided is a method for reducing liver damages associated with the treatment of rheumatoid arthritis with a disease-modifying antirheumatic drug or a non-steroidal anti-inflammatory drug. |
| priorityDate | 2017-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1179.